You are here: Home » Companies » Results
Business Standard

Sun Pharma Q2 net plunges 59% at Rs 912 cr

Analysts on average had expected a profit of Rs 827 crore, according to Thomson Reuters data

Reuters 

India's largest drugmaker, Sun Pharmaceutical Industries Ltd, posted a 59 per cent plunge in second-quarter profit on Tuesday, but beat estimates. Profit came in at Rs 912 crore ($139.48 million) in the quarter ended Sept. 30, compared with Rs 2,235 crore a year ago, the company said.  Analysts on average had expected a profit of Rs 827 crore, according to Thomson Reuters data.

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Tue, November 14 2017. 16:58 IST
RECOMMENDED FOR YOU